-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AC-0676 in Relapsed Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AC-0676 in Relapsed Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AC-0676 in Relapsed Chronic Lymphocytic Leukemia (CLL) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AC-0676 in Refractory Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AC-0676 in Refractory Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AC-0676 in Refractory Chronic Lymphocytic Leukemia (CLL) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ACE-1831 in B-Cell Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ACE-1831 in B-Cell Non-Hodgkin Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACE-1831 in B-Cell Non-Hodgkin Lymphoma Drug Details: ACE-1831 is under development...
-
Product Insights
Likelihood of Approval Analysis for Acute Coronary Syndrome
Overview How likely is it that the drugs in Acute Coronary Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Coronary Syndrome Overview Acute coronary syndrome (ACS) encompasses ST-elevation myocardial...
-
Sector Analysis
NewDental Membranes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Dental Membranes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Dental Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Dental Membranes market for the year 2020 and beyond. Dental Membranes are utilized as barriers to inhibit tissue growth for surgical procedures. Dental membranes are utilized beneath gums and over bone for procedures such as bone grafts for dental implants. Even though dental membranes...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AC-0699 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AC-0699 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) Drug...
-
Product Insights
Likelihood of Approval Analysis for Cough
Overview How likely is it that the drugs in Cough will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cough Overview A cough is a sudden expulsion of air through the large...
-
Thematic Analysis
Augmented Reality (AR) in Agriculture – Thematic Intelligence
Augmented Reality (AR) in Agriculture Thematic Report Overview Augmented reality (AR) is improving productivity and efficiency throughout the agribusiness value chain. AR is increasing the efficiency and efficacy of training in agriculture, using simulations or real-time direction. AR is also reducing the downtime of agricultural machinery by assisting technicians with maintenance. When combined with other emerging technologies such as artificial intelligence (AI) and the Internet of Things (IoT), AR data visualization will support precision agriculture. This prescriptive use of agricultural...
-
Sector Analysis
NewResistant Hypertension (RH) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Resistant Hypertension (RH) Marketed and Pipeline Drugs Report Overview Resistant Hypertension (RH) refers to high blood pressure (BP) that is above the target level in a patient. This occurs even when they are taking three different classes of antihypertensive medications concurrently. These medication classes typically include diuretics, long-acting calcium channel blockers, and renin-angiotensin system blockers (ACEs or ARBs). The Resistant Hypertension (RH) marketed, and pipeline drugs research report includes an assessment of the disease epidemiology, leading marketed products with sales...